This blog may help people explore some of the 'hidden' issues involved in certain media treatments of environmental and scientific issues. Using personal digital images, it's also intended to emphasise seasonal (and other) changes in natural history of the Swansea (South Wales) area. The material should help participants in field-based modules and people generally interested in the natural world. The views are wholly those of the author.
Wednesday, 20 December 2023
First Flush?
Onset of the menopause causes misery for many women. Hot flushes and night sweats reduce their quality of life as well as their productivity. The only treatment thus far has been hormone replacement therapy (HRT). HRT is not, however, appropriate for women with family histories of breast and ovarian cancer. It's also contra-indicated for patients with high blood pressure. Treatment with Veoza (fezolinetant) has, however, recently been approved for use in both the US and the UK (https://www.theguardian.com/society/2023/dec/18/veoza-fezolinetant-menopause-drug-hot-flushes-wins-uk-approval). Veoza relieves menopausal symptoms, like hot flushes, but isn't a hormonal treatment. Additional research needs, however, to be done. For example, women over the age of 65 have not yet been studied in terms of their response to Veoza. There's a (remote?) possibility, that extended treatment in this cohort, could have detrimental effects. This needs to be explored, along with other issues (like ethnicity).
Subscribe to:
Post Comments (Atom)
Our Own Worst Enemy
COP29 is in overtime, as its collective can't agree the final communique. Some nations now want to renege on previous COP 'pledges&...
-
Garden plants in France, The Netherlands, The UK and Sikkim (NE India).
-
Common toadflax ( Linaria vulgaris ) contains a moderately toxic glucoside.
-
The UK's Deputy Prime Minister has been advising Brits on how to 'better prepare for future pandemics, disasters and cyber attacks&...
2 comments:
If you have to pay for the drug, however, it costs more than £400 pa. That doesn't seem fair.
That should have been £400 per month!
Post a Comment